CD274 and hepatocellular carcinoma: The nanoparticles not only successfully inhibited the survival of MDSCs and blocked the compensatory expression of PDL1 on MDSCs by releasing immunomodulators in the transition region of iRAF, but also provided a new strategy for HCC eradication by RAF (Tang et al., 2023).